| ￥9200 | |
| Z06803-200 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Conjugate | iFluor 647 | ||||
| Biological Activity | Immobilized Human BAFF/TNFSF13B/CD257, His at 1 μg/ml (100μl/well) on the plate can bind BCMA(TNFRSF17) hFc Chimera [iFluor 647], Human (Cat.No.: Z06803). | ||||
| Theoretical Molecular Weight | 31.4 kDa | ||||
| Formulation | Supplied in PBS (pH 7.2), containing 10 mg/ml BSA, 0.03% ProClin300 and 50% glycerol. | ||||
| Concentration | 0.5 mg/mL | ||||
| Storage & Stability | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||
|
|||||
Flow cytometric analysis of anti-BCMA-based CAR-T cells using BCMA(TNFRSF17) hFc Chimera [iFluor 647], Human (Z06803).
The results show that Z06803 can achieve good cell clustering for CAR-transduced T cells. ?
| Target Background | BCMA (B-cell maturation antigen), also called TNFRSF17, is encoded by the TNFRSF17 gene. It acts as a cell surface receptor of the TNF receptor superfamily. BCMA recognizes B-cell activating factor (BAFF). It interacts with the B-cell activating factor TNFSF13B. |
| Synonyms | CD269; TNFRSF17; BCMA; BCM; TNFRSF13A |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
